Baseline Prefrontal Network — Weak Alpha-2A Signaling
Under-connected prefrontal circuits reduce working memory and impulse control.
- ~8%: Alpha-2A activation (unmedicated baseline)
- ~22%: PFC connectivity (sparse network state)
- ~31%: WM / impulse score (reduced regulation)
- Alpha-2A: Target receptor (postsynaptic, PFC-enriched)
Why prefrontal connectivity matters
Weak signaling loosens network "tuning" that supports focus.
ADHD and network under-connectivity
Sparse PFC networks correlate with inattention and impulsivity.
Guanfacine — Direct Postsynaptic Alpha-2A Stimulation
Guanfacine directly stimulates alpha-2A receptors, a distinct mechanism.
- Intuniv: Brand name (extended-release guanfacine)
- Alpha-2A agonist: Mechanism class (not a stimulant)
- Different MOA: Vs. atomoxetine (no reuptake blockade)
- Days–weeks: Onset window (gradual titration)
Direct receptor agonism
Guanfacine binds postsynaptic alpha-2A receptors directly in PFC.
Contrast with reuptake inhibitors
Atomoxetine blocks norepinephrine reuptake; guanfacine acts postsynaptically.
Alpha-2A Activation Strengthens Cortical Connections
Receptor activation progressively strengthens prefrontal network connections.
- ~74%: Alpha-2A activation (rising with dose)
- ~61%: PFC connectivity (edges densify)
- HCN channels: Ion channel target (closed by cAMP signaling)
- Increased gain: Network effect (signal-to-noise improves)
Cellular signaling cascade
Alpha-2A activation reduces cAMP, closing HCN channels, sharpening tuning.
Network-level consequence
Stronger synaptic connections raise effective prefrontal connectivity.
Enhanced Connectivity Improves Working Memory and Control
Denser networks translate into better working memory and impulse control.
- ~76%: WM / impulse score (substantial gain)
- ~82%: PFC connectivity (near-dense network)
- Regulation: Behavioral domain (inhibition, attention span)
- Weeks: Timeframe (to full clinical effect)
Working memory circuits
Delay-period neuron firing stabilizes as connectivity strengthens.
Impulse control gains
Stronger top-down PFC control improves behavioral inhibition.
Outcome — Symptom Relief and the Sedation Trade-off
ADHD symptoms improve; sedation often favors evening dosing.
- Improved: ADHD symptom relief (core inattention/impulsivity)
- Tics, ODD: Comorbid benefit (may also improve)
- Sedation: Common side effect (especially daytime dosing)
- Evening: Dosing consideration (reduces daytime sedation impact)
Symptom and comorbidity benefit
Improved attention, impulse control; possible tic/ODD symptom relief.
Sedation and dosing strategy
Evening dosing lessens the practical impact of sedation.